Loading market dashboard
Chemomab Therapeutics Ltd.
CMMBHealthcareNASDAQIL
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Chemomab Therapeutics Ltd. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $36.18M | $36.18M - $36.18M | $0.00 | -$0.04 | 1 |
| Dec 2029 | $35.47M | $35.47M - $35.47M | $0.00 | -$0.04 | 1 |
| Dec 2028 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.04 | 0 |
| Dec 2027 | $36.20M | $36.20M - $36.20M | $0.00 | -$0.03 | 2 |
| Dec 2026 | $24.40M | $24.40M - $24.40M | $0.00 | -$0.02 | 2 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.08 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.28 | 0 |